Chronic myelogenous leukemia for primary care physicians

Dis Mon. 2012 Apr;58(4):168-76. doi: 10.1016/j.disamonth.2012.01.007.
No abstract available

Publication types

  • Review

MeSH terms

  • Benzamides
  • Biopsy, Fine-Needle
  • Bone Marrow / pathology
  • Dasatinib
  • Disease Progression
  • Female
  • Fusion Proteins, bcr-abl / genetics
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / epidemiology
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Leukocytosis / etiology
  • Philadelphia Chromosome
  • Piperazines / therapeutic use
  • Platelet Count
  • Pregnancy
  • Pregnancy Complications, Neoplastic
  • Primary Health Care
  • Protein Kinase Inhibitors / therapeutic use
  • Pyrimidines / therapeutic use
  • Thiazoles / therapeutic use
  • Translocation, Genetic

Substances

  • Benzamides
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Thiazoles
  • Imatinib Mesylate
  • Fusion Proteins, bcr-abl
  • nilotinib
  • Dasatinib